Log in to save to my catalogue

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppress...

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppress...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5f90acace1374b91a2c015209af90f64

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression

About this item

Full title

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2017-11, Vol.8 (1), p.1811-14, Article 1811

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

While chemotherapy delivery by nanocarriers has modestly improved the survival prospects of pancreatic ductal adenocarcinoma (PDAC), additional engagement of the immune response could be game changing. We demonstrate a nano-enabled approach for accomplishing robust anti-PDAC immunity in syngeneic mice through the induction of immunogenic cell death...

Alternative Titles

Full title

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5f90acace1374b91a2c015209af90f64

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5f90acace1374b91a2c015209af90f64

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-017-01651-9

How to access this item